Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS LLC | 05-15-2024 | 03-31-2024 | 26 | 1,244,287,799 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | 1 | $247,708,042 | 10,473,913 | 0.02 | 10.11 | 2,173,913 | 26.19 | 03-31-2024 |
| NUVALENT INC | COM | 2 | $202,537,779 | 2,697,267 | 0.02 | 11.90 | -880,000 | -24.60 | 03-31-2024 |
| SPRINGWORKS THERAPEUTICS INC | COM | Liquidated | $0 | 0 | 14.04 | 13.95 | 0 | 0.00 | 03-31-2024 |
| DIANTHUS THERAPEUTICS INC | COM | 4 | $89,760,840 | 2,992,028 | 0.01 | 2,992,028 | +Inf | 03-31-2024 |
